EnglishFrenchGermanItalianSpanish

WELCOME TO THE NEWSROOM

WATCH OUR LATEST VIDEO

In the news

Find our most recent press releases and other media below. CONTACT US if you need more details, would like to set up an interview or are a media person on deadline.

QIAGEN to launch two Sample to Insight systems in Europe and other markets, NeuMoDx™ to commercialize in the U.S. / Initial assay menu for infectious diseases and LDTs Hilden, Germany, and Ann Arbor, Michigan, September 17, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx™ Molecular, Inc. today announced a strategic partnership to...

Ann Arbor, Michigan (July 1, 2018) – NeuMoDx™ Molecular, a sample-to-result molecular diagnostic company focused on central laboratory customers, announced today it will be previewing its FDA 510(k) cleared NeuMoDx™ 288 Molecular System during the 70th AACC Annual Scientific Meeting and Clinical Lab Expo to be held in Chicago, IL July 29th- August 2, 2018. NeuMoDx™...












































































Coronavirus Assay Information

NeuMoDx™ Molecular, a sample-to-result molecular diagnostic company focused on providing testing solutions to hospital and commercial reference laboratories, has developed a SARS-CoV-2 Assay for use on the high throughput, fully automated NeuMoDx™ 288 and 96 Molecular Systems. The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the NeuMoDx™ SARS-CoV-2 Assay implemented on the NeuMoDx™ Molecular Systems.

To learn more about SARS-CoV-2 testing, click here.
To order, click here.